SGLT2 Inhibitor Therapy for Transthyretin Amyloid Cardiomyopathy: Early Tolerance and Clinical Response to Dapagliflozin

Stephan Dobner(University of Bern), Lukas Hunziker(University of Bern), Christoph Gräni(University Hospital of Bern), Stephan Windecker(University of Bern), Thomas Pilgrim(University Hospital of Bern), Babken Asatryan(University of Bern), Stefan Stortecky(University of Bern), Benedikt Bernhard(University of Bern)
ESC Heart Failure
October 19, 2022
Cited by 61


Related Papers